Parent Tells Committee Pharmacy Transfer Rules Leave Families Without ADHD Medication

Will Pangyan of Lunenburg told the Joint Committee on Financial Services that restrictions on transferring prescriptions within a pharmacy chain can leave families scrambling when a local store is out of stock of essential ADHD medications such as Vyvanse.

“If one pharmacy is out of stock, we're often forced into a frustrating loop — back to the doctor for a brand‑new prescription, then off to another pharmacy hoping they'll have it,” Pangyan said. He described repeated trips to clinicians and pharmacies, missed work and school, and the stress of uncertain medication access for his twin children, both of whom are autistic and have ADHD.

Pangyan urged lawmakers to change rules so that patients can transfer control of prescriptions between pharmacies in the same chain. He said the change would reduce administrative burden, lower costs and speed access to care for families juggling appointments and activities.

Committee members accepted the testimony and did not ask follow‑up questions. The item was part of a broader hearing with multiple health‑policy witnesses; no bill number was cited during Pangyan’s remarks.

Why it matters: witnesses framed the request as a narrow, practical fix to reduce unnecessary medical visits and delays in ongoing treatment, particularly for children who rely on stimulant medications to function at school and home.

The hearing concluded with no committee action on this matter.